We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NXE:NYSENexgen Energy Ltd. Analysis

Data as of 2026-06-13 - not real-time

$9.85

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

NexGen Energy (NXE) is trading at $9.85, comfortably above the identified support of $9.17 but still below its 20‑day ($10.78), 50‑day ($11.63) and 200‑day ($10.42) simple moving averages, indicating a short‑term downtrend. The 14‑day RSI of 39 suggests the stock is approaching oversold territory, while a bearish MACD histogram (‑0.15) reinforces momentum weakness. Volatility is extremely high at 68% over the past 30 days and a beta of 2.11 signals amplified moves relative to the market, which aligns with the “Extreme Greed” reading (89.86) on the fear‑greed index, hinting at strong speculative interest.
Fundamentally, NXE reports no revenue and negative earnings, with a trailing EPS of –$0.49 and a forward EPS still in the red, reflecting its exploration‑stage status. Nonetheless, the company holds $1.02 bn in cash against $721 m of debt, providing a solid liquidity cushion, and recent news of federal clearance to commence its flagship uranium mine and a new CFO appointment underpin a potential catalyst pipeline. Analyst coverage is limited but the sole rating is a “strong buy” with a median target price of $25.65, implying a 160% upside from current levels.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price is below all major SMAs indicating bearish technical bias
  • bearish MACD histogram and negative signal line
  • RSI near oversold but volatility remains elevated

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • federal clearance to break ground on flagship uranium mine
  • strong cash position relative to debt
  • analyst’s strong‑buy rating with a $25.65 target price

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • long‑term uranium demand driven by SMR and nuclear revival
  • potential upside of >160% versus current price
  • absence of dividend pressure allows reinvestment into project development

Key Metrics & Analysis

Financial Health

P/E Ratio-56.3
ROE-29.61%
ROA-3.04%
Debt/Equity42.47
P/B Ratio4.9
Op. Cash Flow$-56874000
Free Cash Flow$-280498752
Industry P/E21.5

Technical Analysis

TrendNeutral
RSI39.1
Support$9.17
Resistance$12.50
MA 20$10.78
MA 50$11.63
MA 200$10.42
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Target Price$25.65
Upside/Downside160.41%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.11
Volatility67.77%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.